Anesthesia Protocol for Electroconvulsive Therapy (ECT)
Administer methohexital 1.0 mg/kg IV as the primary anesthetic agent, succinylcholine 0.9 mg/kg IV for muscle relaxation, and atropine or glycopyrrolate IV for anticholinergic prophylaxis, followed by 100% oxygen ventilation before delivering the electrical stimulus. 1, 2
Pre-Procedure Requirements
Patient Preparation
- Ensure the patient has fasted for approximately 12 hours before the procedure 3, 4
- Verify that an anesthesiologist experienced in treating the patient population is present 3
- Confirm emergency airway equipment is immediately available 5
Medication Review and Discontinuation
- Discontinue lithium when clinically possible due to risk of acute brain syndrome 4, 6
- Stop benzodiazepines as they increase seizure threshold 3, 6
- Discontinue trazodone due to risk of prolonged seizures 4, 6
- Stop carbamazepine as it may prevent seizure induction 4, 6
- Discontinue theophylline as it prolongs seizure duration at all levels 3, 6
- If medications cannot be stopped due to clinical necessity, continue with appropriate monitoring 3, 4
Anesthetic Medication Protocol
Step 1: Anticholinergic Premedication
Administer atropine or glycopyrrolate IV immediately before ECT to prevent vagally-induced bradycardia, arrhythmias, and potential cardiac asystole 3, 4
- This is mandatory before seizure threshold determination and before the first treatment with right unilateral electrode placement 3, 4
- Protects the cardiovascular system from vagal discharge during incomplete or missed seizures 3
Step 2: Primary Anesthetic Agent
Administer methohexital 1.0 mg/kg IV slowly over 60 seconds 1, 2, 7
- Methohexital is the preferred anesthetic agent recommended by the American Academy of Child and Adolescent Psychiatry 1
- Rapid administration may result in respiratory depression and enhanced vasopressor response 5
- The 100 mg/mL concentration must be diluted with an equal volume of Sterile Water, Normal Saline, or 5% Dextrose before IV administration 5
Alternative Anesthetic Agents (if methohexital unavailable)
- Etomidate 0.15-0.3 mg/kg IV: Produces longer seizure durations than methohexital and is advantageous in seizure-resistant patients 3, 1, 8, 9
- Ketamine 1-4.5 mg/kg IV administered slowly over 60 seconds: Alternative agent, though less commonly used 3, 5
- Thiopental sodium: Acceptable alternative but may increase seizure threshold 3, 1
- Propofol 0.75-1.5 mg/kg IV: Associated with shortest seizure durations but does not compromise antidepressant efficacy; use lowest effective dose 1, 10, 9
Step 3: Muscle Relaxation
Administer succinylcholine 0.9 mg/kg IV 1, 2, 7
- Succinylcholine is the standard muscle relaxant recommended by the American Academy of Child and Adolescent Psychiatry 1
- There is considerable variability in patient response to this drug 2
Alternative Muscle Relaxants
Step 4: Oxygenation
Ventilate the patient with 100% oxygen before administration of the electrical stimulus 3, 1, 4
- This step is critical to prevent hypoxia-related complications during the seizure 3
During ECT Administration
Monitoring Requirements
- Continuously monitor vital signs, airway patency, seizure duration, and adverse effects 3
- Monitor for both motor and EEG seizure activity using an ECT device with EEG recording capacity 3
- Observe for purposeless and tonic-clonic movements of extremities, which do not indicate need for additional anesthetic 3
Management of Prolonged Seizures
If seizure duration exceeds 180 seconds, terminate with additional methohexital, diazepam, or lorazepam 3, 6
- Prolonged seizures are associated with greater postictal confusion, amnesia, and increased hypoxia-related risks 3
- Obtain neurology consultation if recurrent prolonged seizures or tardive seizures occur 3, 6
Post-Procedure Recovery
Immediate Recovery
- Recover the patient in a specially designated area with expert nursing care 3
- Continue monitoring until fully recovered from anesthesia 3
Extended Monitoring
- Monitor for at least 24 hours for tardive seizures that may occur after the ECT session 3, 6
- Tardive seizures are rare but potentially serious, usually occurring in patients with normal pre-treatment EEG who are not receiving seizure-lowering medications 3
Maintenance Anesthesia for Repeated Treatments
Repeat Dosing
- Administer increments of one-half to the full induction dose as needed for maintenance 3
- Adjust dose based on anesthetic needs and whether additional anesthetic agents are employed 3
Continuous Infusion Option
- Methohexital 0.1-0.5 mg/minute by slow microdrip infusion maintains general anesthesia 3
- For dilute solution: Add 10 mL of 50 mg/mL vial or 5 mL of 100 mg/mL vial to 500 mL of 5% Dextrose or Normal Saline to achieve 1 mg/mL concentration 5
Critical Pitfalls to Avoid
- Never withhold anticholinergic premedication during seizure threshold determination or first unilateral treatment, as this leaves patients vulnerable to vagally-induced cardiac complications 4
- Never administer the 100 mg/mL concentration of ketamine IV without proper dilution 5
- Never rapidly administer methohexital or ketamine, as this causes respiratory depression and enhanced vasopressor response 5
- Avoid propofol in seizure-resistant patients, as it produces the shortest seizure durations among anesthetic agents 10, 9
- Do not co-administer theophylline or aminophylline with ketamine, as this lowers seizure threshold 5
Special Population Considerations
Adolescents
- Adolescents may have lower seizure thresholds and more prolonged seizures than adults, requiring adjusted anesthetic dosing 1, 4, 6
- Consider propofol for management of prolonged seizures in this population 1
- ECT should only be administered on an inpatient basis for adolescents to better monitor treatment response and recovery 3